|
|
现在注册，加入深空
您需要 登录 才可以下载或查看，没有帐号？加入深空
x
In an Asian phase II III trial ATTRACTION 4 reported in The Lancet Oncology, Yoon Koo Kang, MD, and colleagues found that the addition of nivolumab to oxaliplatin based chemotherapy improved progression free survival but not overall survival as first line treatment of HER2 negative, unresectable, <a href=http://cialis.lat/discover-the-best-prices-for-cialis>buy cheap cialis online</a> |
|
窥视卡
雷达
发表于 2024-8-15 10:10:47
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
千斤顶
照妖镜